Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose radiotherapy versus intravenous ibandronate for localized metastatic bone pain
ISRCTN86185157Phase 3Completed
- Sponsor
- Cancer Research UK
- Start
- Apr 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of ibandronate in bone metastases, breast cancer, bronchial carcinoma and 1 more (2 arms), sponsored by Cancer Research UK. Primary endpoints: Pain response at 4 weeks and Pain response at 12 weeks. Started Apr 2003; status: completed.
02
Drugs
ibandronate
03
Conditions
bone metastasesbreast cancerbronchial carcinomaprostate cancer (PCa)
Beyond the preview
Go deeper on ISRCTN86185157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN86185157.